Hyperkalemia Drugs Market- 38% of Growth to Originate from North America| |Evolving Opportunities with AdvaCare International & Ardelyx Inc |17000+ Technavio Reports – Yahoo Finance

NEW YORK, April 6, 2022 /PRNewswire/ — The Hyperkalemia Drugs Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. The hyperkalemia drugs market value is anticipated to grow by USD 803.17 million from 2021 to 2026 progressing at a CAGR of 18.65% as per the latest market report by Technavio. 38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the hyperkalemia drugs market in North America. Market growth in this region will be faster than the growth of the market in ROW. The increasing prevalence of chronic kidney diseases and heart failure caused by the growing sedentary lifestyle will facilitate the hyperkalemia drugs market growth in North America over the forecast period.
For more insights on the market share of various regions – Download a free sample now!
Market Dynamics
Factors such as growing cases of chronic diseases, the growing use of various therapeutics, and the increasing prevalence of hyperkalemia will drive the growth of the Hyperkalemia Drugs Market. However, poor diagnosis might hamper the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Company Profiles
The hyperkalemia drugs market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market. The hyperkalemia drugs market report includes information on the product launches, sustainability, and prospects of leading vendors including AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd.
Few companies with their key offerings
AdvaCare International – The company offers hyperkalemia drugs as relief in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy, under the brand name CalcoCare.
Ardelyx Inc. – The company offers a hyperkalemia drug that targets potassium secretion through the lumen of the gut, which is still in development under RDX013.
AstraZeneca Plc – The company offers a hyperkalemia drug that provides rapid and sustained potassium control for patients, under the brand name Lokelma.
CytoSorbents Corp. – The company offers a hyperkalemia drug designed to treat cases of moderate to severe hyperkalemia where dialysis is not available, under the brand name Kontrol.
KVK Tech Inc. – The company offers hyperkalemia drugs such as sodium polystyrene sulfonate powder, under the brand name Kayexalate.
To know about all major vendors with their key offerings – Download a free sample now!
Competitive Analysis
The competitive scenario provided in the hyperkalemia drugs market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation
By Type, the market is classified into chronic hyperkalemia and acute hyperkalemia.
By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW).
To know about the contribution of each segment – Download a free sample now!
Related Reports –
The retinal drugs market size has the potential to grow by USD 6.28 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.10%. Download a free sample now!
The schizophrenia drugs market share should rise by USD 957.50 million from 2021 to 2025 at a CAGR of 2.06%. Download a free sample now!
Hyperkalemia Drugs Market Scope
Report Coverage
Page number
Base year
Forecast period
Growth momentum & CAGR
Accelerate at a CAGR of 18.65%
Market growth 2022-2026
USD 803.17 million
Market structure
YoY growth (%)
Performing market contribution
North America at 38%
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period,
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Content
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
4 Five Forces Analysis
4.1 Five forces summary
4.2 Bargaining power of buyers
4.3 Bargaining power of suppliers
4.4 Threat of new entrants
4.5 Threat of substitutes
4.6 Threat of rivalry
4.7 Market condition
5 Market Segmentation by Type
5.1 Market segments
5.2 Comparison by Type
5.3 Chronic hyperkalemia – Market size and forecast 2021-2026
5.4 Acute hyperkalemia – Market size and forecast 2021-2026
5.5 Market opportunity by Type
6 Customer Landscape
6.1 Customer landscape overview
7 Geographic Landscape
7.1 Geographic segmentation
7.2 Geographic comparison
7.3 North America – Market size and forecast 2021-2026
7.4 Europe – Market size and forecast 2021-2026
7.5 Asia – Market size and forecast 2021-2026
7.6 Rest of World (ROW) – Market size and forecast 2021-2026
7.7 US – Market size and forecast 2021-2026
7.8 Germany – Market size and forecast 2021-2026
7.9 Canada – Market size and forecast 2021-2026
7.10 France – Market size and forecast 2021-2026
7.11 UK – Market size and forecast 2021-2026
7.12 Market opportunity by geography
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
9.3 Landscape disruption
9.4 Industry risks
10 Vendor Analysis
10.1 Vendors covered
10.2 Market positioning of vendors
10.3 AdvaCare International
10.4 Ardelyx Inc.
10.5 AstraZeneca Plc
10.6 CytoSorbents Corp.
10.7 KVK Tech Inc.
10.8 Sanofi SA
10.9 Steadfast MediShield Pvt. Ltd.
10.10 Vifor Pharma Management Ltd.
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
11.3 Currency conversion rates for US$
11.4 Research methodology
11.5 List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperkalemia-drugs-market–38-of-growth-to-originate-from-north-america-evolving-opportunities-with-advacare-international–ardelyx-inc-17000-technavio-reports-301517988.html
SOURCE Technavio
It looks like millennials have totally solved the retirement crisis. A new survey of 4,000 people by Investopedia found that more millennials own cryptocurrencies than own stocks. More millennials told the survey they were planning to rely on cryptocurrencies in retirement than said they were planning to rely on mere “savings.”
Big oil companies aren't the money-gushers they once were, and efforts to punish them for high gas prices could make the problem worse.
BUDAPEST/LONDON (Reuters) -Hungary said on Wednesday it was prepared to pay roubles for Russian gas, breaking ranks with the European Union which has sought a united front in opposing Moscow's demand for payment in the currency. Hungary will pay for shipments in roubles if Russia asks it to, Prime Minister Viktor Orban told a news conference on Wednesday in reply to a Reuters question. Russian President Vladimir Putin has warned Europe it risks having gas supplies cut unless it pays in roubles as he seeks retaliation over Western sanctions for Moscow's invasion of Ukraine.
Gogoro CEO Horace Luke joins Yahoo Finance Live to discuss taking the EV startup public via SPAC and the outlook for electric mobility.
CEO for a decade, former Googler Eric Schmidt says in-person work is essential to success and learning management skills. His former HR chief says the return to office is a "boil the frog method."
At least a dozen U.S. shale gas executives met on Wednesday with European energy officials to discuss expanding U.S. fuel supplies to Europe amid a scramble to replace Russian imports. The European Union plans to cut its reliance on Russian gas by two-thirds this year. Delegations from Latvia and Estonia, diplomats from Bulgaria, Estonia, France, Germany, Hungary, Latvia, and the UK toured the Golden Pass LNG export project in Sabine Pass, Texas, and later met in Houston with shale gas producers, said Fred Hutchison, chief executive of trade group LNG Allies.
Oil executives told lawmakers on Wednesday they can't take away the pain consumers are feeling at the pump.
(Bloomberg) — Boeing Co. is hiring the three biggest U.S. cloud-computing companies — Amazon.com Inc., Microsoft Corp. and Alphabet Inc.’s Google — to help with a digital makeover aimed at giving its airplane designers and software developers more tools.Most Read from BloombergU.S. Drones for Ukraine Will Include Latest Tank KillersRussia Skirts Nearer Default After Dollar Payment BlockedEx-Oligarch Says Putin Sees War With the West Already UnderwayFed Officials Weigh Pruning Balance Sheet by
For older workers who retired and are considering a return to the workplace, the tight labor market is promising.
Many adults approaching retirement age have little to no retirement savings. In fact, the U.S. Government Accountability Office said that almost 50% of households headed by someone aged 55 and older had no retirement savings in 2016. And as the retirement age … Continue reading → The post Here's a New Way to Generate Lifetime Income for Retirement appeared first on SmartAsset Blog.
A House panel will hold a hearing this week with oil company executives as consumers across the country allege gasoline price gouging at the pump, where drivers last month paid record-high prices per gallon for the fuel. But experts have a reasonable explanation for the climb.
Laurence Kotlikoff, author of “Money Magic: An Economist's Secrets to More Money, Less Risk, and a Better Life," shares his advice for retirement planning.
He also criticized the proposed delisting of Russian companies' depositary receipts from foreign exchanges, saying this would increase risks and undermine the rights of shareholders. Russian President Vladimir Putin has ordered that natural gas, exported mostly to Europe, be paid for in roubles instead of foreign currency following sweeping Western sanctions over Ukraine. European capitals have rejected the demand, which Germany said amounted to "blackmail".
(Bloomberg) — U.S. coal miners including Peabody Energy Corp. are surging as the European Union proposes banning imports of the fuel from Russia. But it will be difficult, if not impossible, for them to fill the potential supply gap. Most Read from BloombergU.S. Drones for Ukraine Will Include Latest Tank KillersA 30-Year-Old Crypto Billionaire Wants to Give His Fortune AwayUkraine Update: Zelenskiy to Address UN Body; China Holds TalksRussia’s Effort to Avoid Default Undermined by New U.S. San
Volkswagen’s days as one of the world’s biggest car makers are numbered after revealing plans to slash its model range to focus on fewer, more profitable vehicles.
Digital transformation (DX) is a somewhat nebulous term that refers to the ongoing need to keep pace with technology. Organizations are constantly under pressure to operate more efficiently, work more productively, and provide a better customer experience. Companies like Snowflake (NYSE: SNOW) and Zscaler (NASDAQ: ZS) are well-positioned to benefit from that DX tailwind, and both stocks could make you richer by retirement, whether that's in five years or a few decades.
Use this airfare saving tip, says one Wall Street analyst who covers the industry.
(Bloomberg) — Across Ukraine’s farm belt, silos are bursting with 15 million tons of corn from the autumn harvest, most of which should have been hitting world markets.Most Read from BloombergA 30-Year-Old Crypto Billionaire Wants to Give His Fortune AwayU.S. Drones for Ukraine Will Include Latest Tank KillersElon Musk Takes 9.2% Stake in Twitter After Hinting at Shake-UpUkraine Update: Zelenskiy to Address UN Body; China Holds TalksChina Finds New Virus Subtype as Daily Cases Exceed 13,000The
Moderna's (NASDAQ: MRNA) bread and butter at the moment is Spikevax, its coronavirus vaccine. Early Tuesday morning, Bloomberg reported that both the African Union and COVAX have decided not to opt for the additional shots. Citing an email from a Moderna spokesperson, the news agency said that the African Union — a bloc of 55 member states from that continent — declined the 60 million dose option it held for the second quarter of this year.
Yahoo Finance Live's Julie Hyman and Brian Sozzi discuss stock dips for Frontier and JetBlue over the bid to acquire Spirit Airlines.


Add a Comment

Your email address will not be published. Required fields are marked *